Advances in targeted therapy for acute myeloid leukemia

Acute myeloid leukemia (AML) is a clonal malignancy characterized by genetic heterogeneity due to recurrent gene mutations. Treatment with cytotoxic chemotherapy has been the standard of care for more than half of a century. Although much progress has been made toward improving treatment related mor...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biomark Res
Asıl Yazarlar: Yu, Jifeng, Jiang, Peter Y. Z., Sun, Hao, Zhang, Xia, Jiang, Zhongxing, Li, Yingmei, Song, Yongping
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7238648/
https://ncbi.nlm.nih.gov/pubmed/32477567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-020-00196-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller